Platform
Features
Pricing
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Industries
Headquarters
Employees
Links
John A. Scarlett
19 members
14 members
11 members
5 members
6 members
View all
Roivant Sciences
56 followers
Beam
9 followers
Schrödinger
8 followers
ElevateBio
5 followers
Alector
3 followers
Headway
21 followers
Nurix
BioAgilytix
2 followers
ImmunityBio
Avid Bioservices
Allogene Therapeutics
1 follower
Explore companies